A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
6,042 strains of Staphylococcus aureus, Streptococcus faecalis, Proteus mirabilis, Escherichia coli, Klebsiella sp. and Pseudomonas sp. were tested against tobramycin and gentamicin. Among all species studies, except Pseudomonas sp, gentamicin turned out to be slightly superior to tobramycin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011513:Proteus mirabilis / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D014031:Tobramycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D014031:Tobramycin